Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI

Genetic variability has been shown to affect statin responsiveness. Participants from the Utrecht Cardiovascular Pharmacogenetics (UCP) studies were enrolled from a population-based registry of pharmacy records linked to hospital discharge records (PHARMO) to investigate tagging SNPs within candidat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peters, Bas J.M., Pett, Helmi, Klungel, Olaf H., Stricker, Bruno H. Ch., Psaty, Bruce M., Glazer, Nicole L., Wiggins, Kerri L., Bis, Josh C., de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3465613/
https://ncbi.nlm.nih.gov/pubmed/21741043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2011.06.023
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares